IUPAC Traditional

[(1-cyclopentylpiperidin-4-yl)methyl]({[1-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl})[(oxolan-2-yl)methyl]amine

Compound number MolPort-005-090-031
Molecular weight 440.607
InChI key QPTGQLRKAKLCFF-UHFFFAOYSA-N
Molecular formula C26H37FN4O
DMSO Solubility soluble
SMILES Fc1ccc(cc1)-n1cc(CN(CC2CCCO2)CC2CCN(CC2)C2CCCC2)cn1
Best offer
$90.00
Including direct shipping

Pack size:
1 mg
Shipping to:
United States
Lead time:
21 business days
Adjust Requirements

ChemBridge Corporation

Direct S&H to USA
45.00 USD
Catalog
Screening compound
Ships out
21 business days
Purity
90.00
Last updated
last month
In warehouse
1.00 mg
Salt: FREE

Supplier Catalogue Data

Pack size
Ships out
Price
Quantity
1 mg
December 30, 2022
45.00 USD
Simpler, smarter compound sourcing with Molport
  • Extensive vetted supplier network
  • Smart standardised systems and intelligent fulfilment
  • Experienced support and expert lab services
We supply companies including
Fraunhofer logo Domainex logo Reverie labs logo
Search and order chemical compounds instantly
View search options
Access and search our databases offline
Access databases

More Information

Compound identifiers

Compound number
MolPort-005-090-031

Names, Synonyms and 3rd Party Identifiers

Name
1-(1-cyclopentyl-4-piperidinyl)-N-{[1-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}-N-(tetrahydro-2-furanylmethyl)methanamine

InChI

InChI
1/C26H37FN4O/c27-23-7-9-25(10-8-23)31-19-22(16-28-31)18-29(20-26-6-3-15-32-26)17-21-11-13-30(14-12-21)24-4-1-2-5-24/h7-10,16,19,21,24,26H,1-6,11-15,17-18,20H2
InChI key
QPTGQLRKAKLCFF-UHFFFAOYSA-N

Formula

Molecular formula
C26H37FN4O
Molecular weight
440.607

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback